Don't forget the woman who was meeting with him shortly before she accidentally drown, with an 80lb concrete block around her ankle. Ashley Hinson (47yo) had vowed to expose an elite child trafficking ring… but she ded…
We can call these "The Clinton Extension Cord Murders"
She never thought she could/would lose. Her Pied Piper strategy bit her in the ass.
Sounds rather SETH RICH -ish behavior on the part of the family
Soooo, confirmed Killary kill?
'First time this has happened': Doctors left shocked after clinical trial for cancer drug cures the disease in EVERY participant
Clinical trials for the drug dostarlimab in treating colorectal cancer have had incredible results, curing all patients of their cancer
One researcher said that it was the 'first time this has happened' in a cancer trial
Researchers say that the success of this monoclonal antibody drugis especially important for people of younger ages as cancer treatment can harm fertility
It is still too early to declare the drug a cancer cure because they trial was small and limited in scope, researchers note
June 6, 2022
"A new colorectal cancer drug has shocked researchers with how effective it is against the highly dangerous disease, as it virtually cured it in every member of a clinical trial.
Dostarlimab, a monoclonal antibody drug, smashed expectations in a recent trial run by Memorial Sloan Kettering hospital in New York, sponsored by pharmaceutical giant GlaxoSmithKline (GSK).
A year after the trial's completion, each of the 18 participants had their disease go into complete remission, with doctors unable to find signs of the cancer in their body.
While the trial was small, it is game-changing, and sets up the drug as a potential cure for one of the most dangerous common cancers known.
'I believe this is the first time this has happened in the history of cancer,' Dr Luis Diaz, one of the lead authors of the paper and an oncologist at the Memorial Sloan Kettering Cancer Center told the New York Times.
The 18 patients had all gone through previous treatments for colorectal cancer before the trial, including chemotherapy and risky surgeries.
These painful, life-altering, processes generally come with colorectal cancer, a devastating cancer diagnosis that affects 150,000 Americans every year, according to Cancer.net.
It is the third most common type of cancer in the U.S. and kills around 50,000 people every year - the second highest of any cancer.
Patients enrolled in the study received monoclonal antibody treatments every three weeks for six months.
Researchers followed up with the patients 12 months later, and the cancer had seemingly vanished from their bodies, with researchers unable to find signs of tumors with any of their available screening methods.
'At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up,' researchers wrote in the study published in the New England Journal of Medicine.
Sauce/moar (Daily Fail) :https://www.dailymail.co.uk/health/article-10890467/Doctors-left-shocked-clinical-trial-cancer-drug-cures-disease-participant.html
con't
"As a result, all of the participating patients were able to avoid going through more dangerous, taxing, treatments.
'[The results] enabled us to omit both chemoradiotherapy and surgery and to proceed with observation alone,' researchers wrote.
Surgery and radiation can have permanent effects on fertility, sexual health, and bowel and bladder function.
'The implications for quality of life are substantial, especially among patients in whom standard treatment would affect childbearing potential.'
The treatment came with limited negative side-effects as well. Around 20 percent of participants felt an adverse effect, but they were easily managed.
While this study is ground breaking, and looks like doctors may have stumbled onto a cancer cure, they know it is too early to declare this a miracle drug.
'Although the results of our study are promising, especially given that 12 consecutive patients all had a clinical complete response, the study is small and represents the experience of a single institution,' they wrote.
'These findings must be reproduced in a larger prospective cohort that balances academic and community practices and ensures the participation of patients from a diverse set of racial and ethnic backgrounds.'"
Dostarlimab, a monoclonal antibody drug, smashed expectations in a recent trial run by Memorial Sloan Kettering hospital in New York, sponsored by pharmaceutical giant GlaxoSmithKline (GSK).
>the earlier release of the cures actually results in a overall better outcome for humanity (ie less deaths in the long term).
Right there with ya anon.
Especially since Gates poo pooed this treatment:
"Bill Gates says Trump is wrong to call Regeneron’s monoclonal antibodies ‘a cure’ because it ‘won’t work for everyone’ – but admits it’s the most promising therapeutic so far
Bill Gates says Donald Trump is wrong to call monoclonal antibodies treatment a ‘cure’ for COVID-19, but says it’s the most promising therapeutic in research
‘The word “cure” is inappropriate because it won’t work for everyone,’ Gates said
The monoclonal antibodies are being developed by Regeneron Pharmaceuticals, Eli Lilly, and other companies
President Donald Trump touted monoclonal antibodies as a cure Wednesday, saying he felt better after taking them
On Sunday Trump claimed he was ‘cured’ of the virus, but his doctor has not said if he tested negative for the virus yet"
Sauce/moar: https://thestateindia.com/2020/10/12/bill-gates-says-donald-trump-is-wrong-to-call-regenerons-monoclonal-antibodies-a-cure/